Totus Medicines
Scott Gottlieb is a Partner at New Enterprise Associates, one of the largest venture capital firms globally, since 2007. Additionally, Gottlieb serves as a Senior Fellow at the American Enterprise Institute and an elected member of the National Academy of Medicine. In corporate governance, Gottlieb holds board positions at Pfizer, Illumina, Xaira Therapeutics, Comanche Biopharma, Resilience, Tempus AI, and Aetion. Educational qualifications include a Doctor of Medicine from the Icahn School of Medicine at Mount Sinai and a BA in Economics from Wesleyan University. Gottlieb completed a residency in Internal Medicine at the Icahn School of Medicine from 1999 to 2002.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Totus Medicines
Totus Medicines is applying revolutionary chemical biology technologies to create life-changing covalent therapeutics for untreatable diseases.